BriaCell Therapeutics Corp. (BCTX) Corporate Subsidiaries
BriaCell Therapeutics Corp. (BCTX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BCTX
CIK: 1610820
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 07/31
State: A1
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
MNP LLP
Auditor SinceSince 7/31/2019 12:00:00 AM
Lead Engagement PartnerZahra Bhanji
Audit LocationMississauga, Canada
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-06-26 | 2026-06-26 | 8-K | 0001493152-26-030286 | View SEC Doc Filr Page |
| 10-Q | 2026-06-09 | 2026-04-30 | 10-Q | 0001493152-26-027928 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-05-31 | 8-K | 0001493152-26-026953 | View SEC Doc Filr Page |
| 424B5 | 2026-06-02 | — | 424B5 | 0001493152-26-026759 | View SEC Doc Filr Page |
| 8-K | 2026-03-31 | 2026-03-31 | 8-K | 0001493152-26-014156 | View SEC Doc Filr Page |
| 10-Q | 2026-03-10 | 2026-01-31 | 10-Q | 0001493152-26-009557 | View SEC Doc Filr Page |
| 8-K | 2026-03-09 | 2026-03-05 | 8-K | 0001493152-26-009382 | View SEC Doc Filr Page |
| 25-NSE | 2026-02-26 | — | 25-NSE Filing | 0001354457-26-000220 | View SEC Doc Filr Page |
| 8-K | 2026-02-20 | 2026-02-18 | 8-K | 0001493152-26-007587 | View SEC Doc Filr Page |
| DEF 14A | 2026-02-12 | 2026-02-12 | DEF 14A | 0001493152-26-006390 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-01-23 | — | SCHEDULE 13G Filing | 0001104659-26-006332 | View SEC Doc Filr Page |
| 8-K | 2026-01-15 | 2026-01-13 | 8-K | 0001493152-26-002430 | View SEC Doc Filr Page |
| 424B4 | 2026-01-14 | — | 424B4 | 0001493152-26-002258 | View SEC Doc Filr Page |
| EFFECT | 2026-01-13 | — | EFFECT Filing | 9999999995-26-000157 | View SEC Doc Filr Page |
| S-1MEF | 2026-01-13 | — | S-1MEF | 0001493152-26-002103 | View SEC Doc Filr Page |
| CERT | 2026-01-13 | — | CERT Filing | 0001354457-26-000037 | View SEC Doc Filr Page |
| 8-A12B | 2026-01-13 | — | 8-A12B | 0001493152-26-001969 | View SEC Doc Filr Page |
| CORRESP | 2026-01-08 | — | CORRESP Filing | 0001493152-26-000962 | View SEC Doc Filr Page |
| CORRESP | 2026-01-08 | — | CORRESP Filing | 0001493152-26-000961 | View SEC Doc Filr Page |
| CORRESP | 2026-01-06 | — | CORRESP Filing | 0001493152-26-000535 | View SEC Doc Filr Page |
| CORRESP | 2026-01-06 | — | CORRESP Filing | 0001493152-26-000533 | View SEC Doc Filr Page |
| 8-K | 2025-12-29 | 2025-12-29 | 8-K | 0001493152-25-029363 | View SEC Doc Filr Page |
| FWP | 2025-12-23 | — | FWP | 0001493152-25-028923 | View SEC Doc Filr Page |
| S-1 | 2025-12-23 | — | S-1 | 0001493152-25-028916 | View SEC Doc Filr Page |
| 10-Q | 2025-12-11 | 2025-10-31 | 10-Q | 0001493152-25-027240 | View SEC Doc Filr Page |